K
Ka Shing Cheung
Researcher at University of Hong Kong
Publications - 112
Citations - 3769
Ka Shing Cheung is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 65 publications receiving 2319 citations.
Papers
More filters
Journal ArticleDOI
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Ka Shing Cheung,Ivan Hung,Pierre P.Y. Chan,Kwok-Cheung Lung,Eugene Tso,Raymond W. Liu,Yuk-Yung Ng,Man Y. Chu,Tom Wai-Hin Chung,Anthony Raymond Tam,Cyril C. Y. Yip,Kit-Hang Leung,Agnes Yim Fong Fung,Ricky Ruiqi Zhang,Yansheng Lin,Ho Ming Cheng,Anna J. X. Zhang,Kelvin K. W. To,Kwok H. Chan,Kwok-Yung Yuen,Wai K. Leung +20 more
TL;DR: A systematic review and meta-analysis of published gastrointestinal symptoms and detection of virus in stool, and a analysis of data from a cohort of patients with COVID-19 in Hong Kong found that 17.6% of patientsWith CO VID-19 had gastrointestinal symptoms, and healthcare workers should exercise caution in collecting fecal samples or performing endoscopic procedures in patients with CoV-2—even during patient recovery.
Journal ArticleDOI
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: A population-based study
TL;DR: Long-term use of PPIs was still associated with an increased GC risk in subjects even after HP eradication therapy, and the adjusted absolute risk difference for PPIs versus non-PPIs use was 4.29 excess GC per 10 000 person-years.
Journal ArticleDOI
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
TL;DR: Serological markers can be non‐invasive alternatives to reflect intrahepatic viral replicative activity in chronic hepatitis B and be advocated as a novel serum marker for disease monitoring and prognostication of CHB.
Journal ArticleDOI
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.
Ka Shing Cheung,Wai K. Leung +1 more
TL;DR: Prevention of NOAC-related GIB includes proper patient selection, using a lower dose of certain NOACs and in patients with renal impairment, correction of modifiable risk factors, and prescription of gastroprotective agents.
Journal ArticleDOI
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
Danny Ka-Ho Wong,Wai-Kay Seto,Ka Shing Cheung,Chun-Kong Chong,Fung-Yu Huang,James Fung,Ching-Lung Lai,Man-Fung Yuen +7 more
TL;DR: This data indicates that serum hepatitis B core‐related antigen could be a surrogate marker for intrahepatic cccDNA in hepatitis B infection.